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Educational aims:  
 To review the evidence for respiratory morbidity, in particular long-term adverse outcomes, 
associated with late preterm birth. 
 To consider the mechanisms by which late preterm birth impacts upon respiratory 
development. 
 To recognise interventions which might protect respiratory development and improve 
outcomes for this patient group. 
 
Future research directions: 
The potential for catch-up lung growth in late preterm infants is not fully understood and requires 
careful study in animal models as well as prospective clinical studies. Interventions based upon 
maximising and protecting lung growth should also be evaluated. Useful areas for further exploration 
include, timing of obstetric intervention, effects of nutrition and growth upon respiratory development 
and benefits associated with RSV prophylaxis. 
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Abstract 
In developed countries most preterm births occur between 34 and 37 weeks’ gestation. 
Deliveries during this ‘late preterm’ period are increasing and, since even mild prematurity is 
now recognised to be associated with adverse health outcomes, this presents healthcare 
challenges. Respiratory problems associated with late preterm birth include neonatal 
respiratory distress, severe RSV infection and childhood wheezing. Late preterm birth 
prematurely interrupts in utero lung development and is associated with maternal and early 
life factors which adversely affect the developing respiratory system. This review considers 1) 
mechanisms underlying the association between late preterm birth and impaired respiratory 
development, 2) respiratory morbidity associated with late preterm birth, particularly long-
term outcomes, and 3) interventions which might protect respiratory development by 
addressing risk factors affecting the late preterm population, including maternal smoking, 
early life growth restriction and vulnerability to viral infection.  
 
1 Introduction 
Babies born between 34 and 37 weeks of gestation have, until recently, been considered 
sufficiently mature to be treated similarly to term infants. Whilst for many of these infants 
outcomes are good, it is now recognised that significant maturation occurs during the last 
weeks of gestation, placing late preterm infants at increased risk of adverse health outcomes 
in the neonatal period and beyond.[1, 2] Late preterm delivery interrupts normal in utero 
respiratory development and relative immaturity is compounded by associated adverse 
perinatal factors. These include increased rates of caesarean delivery,[3] and increased rates 
of intrauterine growth retardation[4] and associated maternal factors, including hypertensive 
disorders, diabetes and smoking.[5, 6] Additionally, morbidities incurred during the early 
postnatal period, including neonatal respiratory distress,[1] poor feeding and growth,[7] and 
vulnerability to respiratory viruses[8] have lasting consequences for respiratory development. 
(Figure 1) This is significant since early life lung development is increasingly recognised as a 
determinant of respiratory later health.[9] Moreover, following temporal changes in maternal 
age, infertility treatments, multiple birth prevalence, and obstetric interventions, [10, 11] late 
preterm deliveries now account for the largest and most rapidly increasing proportion of 
preterm births.[12-14]  
 
2 Mechanisms 
Normal lung development proceeds from the embryonic period (day 26-52) through 
pseudoglandular (day 52-week 16), canalicular (17-26 weeks) and saccular periods (24-36 
weeks to term) to the alveolar period; during which alveolar development commences at 36 
weeks’ gestation and continues into postnatal life.[15, 16] Extreme preterm (< 28 weeks) 
and very preterm birth (28-32 weeks) occur, respectively, during the canalicular period; 
characterised by precapillary and bronchiole formation, and the saccular period; characterised 
by capillary proliferation, saccule formation and commencement of surfactant production. 
Late preterm birth occurs during the most rapid period of lung maturation, at the transition 
between saccular and alveolar periods.[17]  
 
Figure 1 mechanisms contributing to poor respiratory outcomes following late 
preterm birth 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 Consequences of prematurity 
Histologic studies suggest preterm birth is associated with structural changes in the lung, 
including increased bronchial muscle, collagen and elastin.[18] Premature exposure to high 
oxygen tension and other aspects of the ex utero environment likely contributes to these 
effects.[19] The maturational processes affected by late preterm birth are those occurring 
during the final weeks of pregnancy; a progressive decrease in air-space wall thickness and a 
simultaneous increase in air-space surface area.[17] These maturation processes are 
proposed to improve parenchymal elastance and airway-tethering. The functional 
consequences of late preterm birth have been hypothesised to include difficulty protecting 
functional residual capacity, and vulnerability to airway collapse and increased airway 
resistance.[20] After late preterm birth, lung fluid clearance is delayed since this is dependent 
upon developmentally regulated epithelial sodium (ENaC) channels.[21] 
 
2.2 Early life factors 
2.2.1 Prenatal growth  
Many of the complications associated with late preterm delivery increase the risk of placental 
insufficiency and in utero growth restriction. Epidemiological data suggest in utero growth 
  
Prenatal Factors 
Postnatal Factors 
Maternal & Obstetric factors: 
Smoking 
Hypertension 
Diabetes 
Pre-eclampsia 
IUGR 
Preterm 
delivery 
Caesarean 
delivery 
 Placental dysfunction 
 
Premature exposure  
to ex utero conditions 
 
Poor lung fluid 
resorption 
Immature 
feeding 
behaviour
s 
Immature 
immune 
responses 
 Poor growth 
 Vulnerable to infection 
L 
u 
g 
n
n
e 
l 
m
L 
o 
n 
e 
d 
t 
p 
v 
e 
restriction might be associated with persistently impaired respiratory development,[22] 
although few studies have specifically followed up late preterm individuals. Due to difficulties 
associated with gestational age assessment, particularly in large population-based studies, 
distinguishing the effects of prematurity and growth restriction is challenging. For example, 
whilst a large meta-analysis of European birth-cohort data, concluded that gestational age at 
birth appears to largely explain the inverse relationship between birthweight and childhood 
asthma, the association found between rapid postnatal weight gain and later wheeze might 
reflect ‘catch-up’ growth in individuals with restricted growth misclassified for gestational 
age[23]. Although the contribution of in utero growth restriction to clinical outcomes remains 
contentious, mechanistic animal studies, nevertheless, suggest structural and functional 
changes in the lung follow restricted prenatal growth.[24, 25]  
 
2.2.2 Postnatal growth  
Late preterm infants are at risk of postnatal growth restriction due to the combined effects of 
increased nutritional demands associated with respiratory and other morbidities, and of 
developmental difficulties with feeding, particularly breastfeeding.[26] Weight gain in babies 
born late preterm falls below expected intrauterine norms[7] and poor growth often persists 
beyond the neonatal period.[27] Millennium study data demonstrate that the odds of being 
underweight at 3 and 5 years of age increase progressively with decreasing gestation, such 
that late preterm infants are at increased risk compared with term infants.[2] However, early 
growth restriction, particularly when followed by rapid catch-up growth, is increasingly 
recognised as a risk factor for obesity.[28] Within the Millennium study the late preterm 
group contained the highest proportion of children classified as obese.[2]  
 
2.2.3 Immunity 
Premature birth interrupts maternal antibody transfer, and immune maturation does not 
occur until midway through the first year of life.[29] Late preterm infants are susceptible to 
lower respiratory tract infections as a consequence of immature humoral immunity. 
Additionally, adaptive cytotoxic T-lymphocyte responses are immature and viral clearance by 
innate immune responses is inefficient.[8]  
 
3 Respiratory morbidity  
3.1 Neonatal  
A 2011 systematic review and meta-analysis concluded that late preterm infants are more 
likely to need mechanical ventilation (RR 4.9; 95% CI, 2.8–8.6), and are at higher risk of 
neonatal respiratory morbidities, including respiratory distress syndrome (RDS) (RR 17.3; 95% 
CI, 9.8–30.6), transient tachypnoea of the newborn (RR 7.5, 95% CI 5.0–11.2), persistent 
pulmonary hypertension (RR 4.9, 95% CI 3.8–6.3), apnoea (RR 15.7, 95% CI 11.8–20.9), 
pneumothorax (RR 3.4, 95% CI 1.8–6.4) and pneumonia (RR 3.5, 95% CI 1.4–8.9).[1] 
Respiratory complications appear to increase proportionately with increasing prematurity,[30] 
although pregnancy complications, particularly those affecting placental function, might 
compound the effects of relative immaturity.[31] Recent studies comparing the neonatal 
outcomes of late preterm with term infants confirm late preterm infants to have higher rates 
of respiratory morbidity[32, 33] and to be more likely to require respiratory support or 
surfactant therapy.[34, 35]  
 
3.2 Infancy and childhood  
Within the late preterm population relatively high rates of respiratory morbidity generate 
significant healthcare activity and costs in infancy and childhood.[36] (Table 1) A US study of 
children under 2 years of age requiring intensive care for a respiratory illness found that 30% 
were born prematurely and over a third of these were born late preterm. Median hospital 
stay was 2 days greater in late preterm infants and, even after adjusting for this, total 
hospital charges were approximately one and a half times those of term infants.[37]  
 
During infancy late preterm infants have rates of hospital admission for RSV infection (57 per 
1000) exceeding those of term infants (30 per 1000), and approaching those of earlier 
preterm infants (66-70 per 1000).[38] Late preterm infants are vulnerable to severe 
symptoms since infection early in the course of immune maturation is associated with greater 
inflammatory responses and sloughing of dead cells,[39]  this is then compounded by having 
relatively smaller airways than term infants.  
 
Retrospective studies suggest late prematurity increases the risk of both childhood wheeze 
and asthma.[2, 40-44] A records-based survey of 7925 children from 31 medical practices 
demonstrated significant associations between late preterm birth and corticosteroid use (OR 
1.68, 95% CI 1.20-2.29) and persistent asthma by 18 months (OR 1.68, 95% CI 1.01-
2.80).[42] Recently, a large prospective cohort found 988 children born at 32-36 weeks’ 
gestation to experience more wheeze and nocturnal cough at school age and also to receive 
more inhaled steroids than 573 term-born children.[44] Not all studies have been in 
agreement, however, particularly at older ages. Data from 537 late preterm and 5650 term-
born children in the Third National Health and Nutrition Examination Survey, for example, 
failed to demonstrate a significant increase in doctor-diagnosed asthma in children aged 2-83 
months.[45]  
 
3.3 Adulthood 
There are few studies and no prospective data describing long-term outcomes. One study of 
over six thousand young adults (25-53 years) found no association between late preterm 
birth and asthma medication use.[46] However, this study relied upon retrospective data and, 
since pregnancy dating by ultrasound scanning was not routine 25-35 years ago, gestational 
dating was limited to estimation based upon last menstrual period data. 
Table 1 Studies comparing long-term outcomes in individuals born late preterm with those in individuals born at term  
 Study design Late preterm  Term Outcomes: late preterm vs term 
Bird et al 2010[36] 
US 
State wide insurance claims case control 
Matched according to propensity score 
Births 2001-2005, excluded multiple births 
and those with congenital anomalies 
5188 infants 
34 0/7-36 6/7 weeks 
15303 infants 
37 0/7-42 6/7 weeks 
Additional first year health costs 
Outpatient $108, 95%CI $58-$158  
Inpatient $597, 95% CI $528-$666 
Total $734, 95% CI $630-$829 
Rehospitalisation within first year OR 1.11, 95% CI 1.01-1.23 
Harju et al 2014[41] 
Finland 
Retrospective single centre case control 
Births 1989-2008 
2355 individuals  
33 0/7-36 6/7 weeks 
22804 individuals 
39 0/7-40 6/7 weeks 
Asthma at any time OR 1.7, 95% CI 1.4-2.0 
Boyle et al 2012[2] 
UK 
Secondary analysis of birth cohort data 
Births 2000-2002 
1107 children 
34 0/7-36 6/7 weeks 
12540 children 
39 0/7-41 6/7 weeks 
Wheeze or asthma at 3 years OR 1.3, 95% CI 1.0-1.5 
Wheeze or asthma at 5 years OR 1.5, 95% CI 1.2-1.8 
Asthma medication at 5 years OR 2.2, 95% CI 1.6-3.1 
Berard et al 2012[40] 
Canada 
Health record based health economic 
analysis 
Births 1997-2000 
2051 children 
33 0/7-36 6/7 weeks 
33682 children 
37 0/7 
Health costs first 2 years of life CR 1.99, 95% CI 1.90-2.09 
Health costs third year of life CR 1.46, 95% CI 1.39-1.54 
Conditions in first 3 years 
Bronchitis/bronchiolitis OR 1.64, 95% CI 1.13-2.  
Asthma OR 1.2, 95% CI 1.11-3.30 
Pneumonia 1.17, 95% CI 1.05-1.30  
Other upper respiratory condition OR 1.16, 95% CI 1.06-1.28 
Other respiratory condition OR 1.23, 95% CI 1.09-1.38 
Crump et al 2011[47] 
Sweden 
National registry data 
Births 1973-1979, excluded multiple births 
22590 adults 
34 0/7-36 6/7 weeks  
626723 adults 
37 0/7-42 6/7 weeks 
Mortality 1-5 years and 18-36 years but not 6-12 or 13-17 years 
inversely related to gestation 
Mortality 18-36 years HR 1.31, 95% CI 1.13-1.50 
Goyal et al 2011[42] 
US 
Retrospective multi-centre cohort study 
from electronic records 
Births 2007, excluded those with 
congenital anomalies 
582 infants 
34 0/7-36 6/7 weeks 
5540 infants 
39 0/7-42 6/7 weeks 
Within first 18 months 
Asthma OR 1.26, 95% CI 0.92-1.73 
Persistent asthma OR 1.68, 95% CI 1.01-2.80 
Corticosteroid use OR 1.66, 95% CI 1.20-2.29 
Acute respiratory visits IRR 1.44, 95% CI 1.24-1.67 
Vrijlandt et al 2013[48] 
Netherlands 
Prospective multi-centre cohort with term 
controls 
988 children  
32 0/7-35 6/7 weeks 
573 children 
38 0/7-41 6/7 weeks 
Respiratory symptoms in first year 22% vs 13%, p<0.001 
Cough/wheeze during a cold age 4 years % vs 3% p<0.001 
Cough/wheeze without a cold age 4 years 23% vs 15% p<0.001 
Use of inhaled steroids age 4 years 9% vs 6% p=0.036 
Asthma age 5 years 10% vs 6% p=0.022 
Abe et al 2010[45] 
US 
Nationally representative cross-sectional 
survey, excluded multiple births 
537 children 
34 0/7-36 6/7 weeks 
5650 children 
37 0/6-41 6/7 weeks 
Aged 2-83 months at time of survey 
Asthma HR 1.3, 95% CI 0.8-2.0 
Crump et al 2011[46] 
Sweden 
National registry data 
Births 1973-1979 
21918 adults 
33 0/7-36 6/7 weeks 
579359 adults 
37 0/7-42 6/7 
Assessed at age 25-35 years 
Extreme preterm birth associated with increased prescription of 
asthma medications but late preterm birth was not 
OR 0.97, 95% CI 0.9-1.04 
Escobar et al 2010[43] 
US 
Registry based prospective cohort 
Births 1996-2002 
4288 children 
34 0/7-36 6/7 weeks 
50092 children 
38 0/7-40 6/7 weeks 
Recurrent wheeze third year of life OR 1.23, 95% CI 1.07-1.41  
Original English language articles investigating late preterm infants with a clear comparison group identified from PubMed, MEDLINE, Embase, and Cochrane trials databases (July 2010-October 
2014) search terms “34 weeks” or “35 weeks” or “36 weeks” and “late preterm” or “near term” and “complications” or “morbidity” or “outcome” including references identified in original articles or 
reviews identified by the above search. Abbreviations: IRR incidence risk ratio, HR hazard ratio, CR cost ratio, OR odds ratio, CI confidence interval.
4 Respiratory physiology  
Studies evaluating the effects of prematurity independent from those of neonatal respiratory 
disease or its treatments have largely recruited late preterm infants since these infants 
generally require less intervention than those born at earlier gestations. Reduced expiratory 
flows at a year of age were reported in a study of 24 healthy preterm infants born at 29-36 
weeks’ gestation. [49] (Table 2) This study used the rapid thoracoadominal compression 
technique to measure maximal forced expiratory flow at functional residual capacity (V’maxFRC), 
3 weeks and one year after birth. V’maxFRC at 3 weeks was not significantly different from 
predicted values based upon age, length and gender: this may, however, reflect 
overestimation of V’maxFRC since physiological elevation of FRC is employed at this age to 
protects lung volume given the flexibility of the chest wall. A later study used the raised 
volume thoracoabdominal compression technique to measure timed forced expiratory flows 
independent of a volume landmark. Reduced forced expiratory flows were found at 8 weeks 
of age in 62 preterm infants (gestations 27-37 weeks) compared with 27 infants born at 
term;[50] forced expiratory flows were also reduced in the late preterm infants at one year of 
corrected gestational age.[51] More recently, passive respiratory mechanics and tidal 
breathing parameters were compared in 31 healthy 33-36 week infants at term-equivalent 
age and 31 term infants within 72 hours of birth. The late preterm infants had decreased 
respiratory compliance, decreased tidal ratio and increased respiratory resistance.[52]  
 
No study has prospectively assessed respiratory physiology in late preterm individuals beyond 
infancy but cross-sectional studies suggest that forced expiratory flows remain reduced 
through childhood and into adolescence. In an early study, spirometry and lung volume 
measurements at 8-15 years were compared between 34 children born preterm (34-36 weeks) 
and 34 term-born siblings.[53] No between group differences in spirometry were identified, 
although both the mean residual volume and residual volume as a proportion of total lung 
capacity in the preterm group were significantly higher than those of the sibling controls. 
More recently, however, data from the Avon Longitudinal Study of Adults and Children 
demonstrate that in children born 33-34 weeks’ gestation spirometry indices are reduced at 
8-9 years of age and that measures of FEV1/FVC and FEF25-75% remain reduced at age 14-17 
years compared to term controls.[54] Little is known about physiological measures other than 
spirometry in late preterm infants; children born extremely preterm, however, have been 
demonstrated to have normal levels exhaled nitric oxide at school age but evidence of airway 
obstruction, ventilation inhomogeneity, gas trapping and airway hyperresponsiveness,[55]  
Table 3 Studies comparing respiratory physiology in individuals born late preterm to that in individuals born at term  
 Measures and technique Preterm  Comparator Outcome difference between term and preterm values 
McEvoy et al 2011[51] 
US 
Respiratory compliance measured 
by single breath occlusion 
Ratio of time to peak expiratory 
flow to expiratory time measured 
from flow volume loops  
FRC from nitrogen washout 
31 infants 
mean SD gestation 
34.1 1.0 weeks 
Without clinical respiratory 
disease  
Tested at term corrected age 
31 infants 
Matched for sex and 
race  
Tested within 72 hours 
of delivery 
Crs 1.14 vs 1.32 ml/cm H2O/kg p<0.02 
TPTEF:TE 0.308 vs 0.423 cm H2O/ml/s p<0.01 
Rrs 0.064 vs 0.043 cm H2O/ml/s p<0.01 
No difference in RR or FRC 
Friedrich et al 2006[50] 
Brazil 
Forced expiratory flows measured 
by the raised volume rapid 
thoracoabdominal compression 
technique 
62 infants 
Mean, SD gestation 
33.4, 2.11  
Less than 48 hour 
supplemental oxygen therapy 
Tested in first 12 weeks of life 
27 term infants without 
respiratory disease 
tested age 0-3 years 
Adjusting for length, age and sex 
FEF50 -92 ml/s (22%) p=0.013 
FEF25-75% -73 ml/s (20%) p=0.024 
FEV0.5 -19 m (13%) p=0.036 
Hoo et al 2002[49] 
UK 
Forced expiratory flows measured 
by the rapid thoracoabdominal 
compression technique 
24 infants 
Mean 33.2 SD 2.2 weeks with 
no respiratory support tested 
at 3 weeks after birth and at a 
corrected age of one year  
Sex-specific prediction 
equation z-scores  for 
term infants 
At 3 weeks mean V'maxFRC z-score -0.06 SD 0.92 
At 1 year mean V'maxFRC z-score -2.0 SD 0.94 
Mean, 95% CI 2nd-1st test z-scores -1.94, -2.27 to -1.60 
 
Friedrich et al 2007[52] 
Brazil 
Forced expiratory flows measured 
by the raised volume rapid 
thoracoabdominal compression 
technique 
26 infants 
Mean, range gestation 
32.7, 30-34 weeks  
Less than 48 hour 
supplemental oxygen therapy 
Tested at one year of age 
24 term infants without 
respiratory disease 
tested age 0-3 years 
FEF50 -85 ml/s p=0.078 
FEF25-75% -97 ml/s p=0.027  
FEV0.5 -16 ml p=0.348 
Todisco et al 1993[53] 
Italy 
Bronchial reactivity to 
methacholine and lung volumes 
34 infants 
Mean 34.9 weeks 
34 sibling controls 
Mean 39.5 weeks 
RV 1.09 ± 0.3 litres late preterm vs 0.84 ± 0.1 litres term <0.01 
RV/TLC 28 ± 6% late preterm vs 22 ± 2% term<0.01 
No difference in bronchial reactivity  
(11.8% late preterm vs 5.9% term hyperreactive) 
Kotecha et al 2012[56] 
UK 
Spirometry  Children born 
33 0/7-34 6/7 weeks  
79 tested 8-9 years 
49 tested 14-17 years 
 
Children born 
37 0/7-43 6/7 weeks 
6144 tested 8-9 years 
4105 tested 14-17 years 
 
8-9 years FEV1 -0.485, 95% CI -0.724 to -0.246 
Also lower FVC, FEF25-75%, FEV1/FVC, FEF25-75%/FVC 
14-17 years FEF25-75% -0.289, 95% CI -0.577 to -0.001  
FEV1/FVC -0.379, 95% CI -0.666 to -0.092 
No significant deficit at gestation 35 0/7 – 36 6/7 weeks 
Original English language articles identified from PubMed, MEDLINE, Embase, and Cochrane trials databases (July 2010-October 2014) search terms “34 weeks” or “35 weeks” or “36 weeks” and 
“late preterm” or “near term” and “complications” or “morbidity” or “outcome” including references identified in original articles or reviews identified by the above search. 
Abbreviations: TPTEF time to peak expiratory flow, TE expiratory time, Crs respiratory system compliance, Rrs respiratory system compliance, FEF50 FEF25-75% forced expiratory flow at 50% and 
between 25 and 75% of the forced vital capacity, FEV0.5 forced expiratory volume in first 0.5 seconds of expiration, V'maxFRC maximal flow at functional residual capacity, RV residual volume, TLC total 
lung capacity, Forced expiratory volume in the first second of expiration, CI confidence interval.
5 Interventions 
5.1 Protecting prenatal lung development 
5.1.1 Obstetric interventions 
Preterm delivery may be spontaneous or indicated in response to adverse maternal or fetal 
conditions. Spontaneous premature deliveries continue to outnumber those attributable to 
obstetric indications, particularly after 34 weeks of gestation where spontaneous deliveries 
account for 80% of births;[57] nevertheless, prematurity due to obstetric intervention is 
increasing.[58] Whilst this increase has been associated with a decrease in stillbirths and 
likely reflects higher rates of maternal or fetal indications for intervention [59], given the 
adverse impact of prematurity upon respiratory development, the relative risks and benefits 
of iatrogenic pregnancy interruption should be carefully considered. For example, a recent 
clinical trial found no increased in neonatal sepsis after expectant compared with 
interventional management of preterm premature rupture of membranes,[60] however, 
pregnancy interruption at 34 weeks’ when compared to interruption at 36 weeks’ gestation is 
associated with increased risk of RDS (RR 8.6; 95% CI 2.7-27.5).[61]  
 
5.1.2 Antenatal corticosteroids 
Antenatal corticosteroid administration has been proposed to increase lung fluid clearance[62] 
and might potentially benefit late preterm infants. Despite this, tocolysis and antenatal 
steroid administration have not traditionally been considered indicated beyond 34 weeks of 
pregnancy. Observational data[63] and a small case controlled study of lung function 
following antenatal steroid administration[64] suggest this treatment may reduce neonatal 
morbidity after late preterm birth. Clinical trials, however, have not shown consistent benefit 
at later gestations.[65, 66] These studies might have been underpowered to demonstrate 
reduced RDS given possible heterogeneity, perhaps with greater benefit in those born by 
elective caesarean section, for example, and the low absolute incidence of RDS.   
 
5.2 Protecting postnatal lung development 
5.2.1 Growth and nutrition 
There is evidence that growth restriction during the final weeks of term pregnancies is 
associated with poorer lung function: for example, small size at birth and rapid postnatal 
‘catch-up’ weight gain have been shown to be associated with reduced infant lung 
function.[67] Since late preterm infants commence ex utero life during the phase of 
development equivalent to the last weeks of a term pregnancy, nutritional support during 
early postnatal life might help to prevent growth restriction and adverse effects upon 
respiratory development. Certainly, in early preterm infants bronchopulmonary dysplasia 
occurs most frequently in those with poor somatic growth.[68] Potential nutritional 
interventions to support respiratory development during the early life include appropriate 
breastfeeding support,[69] acknowledging the immaturity of feeding behaviour in late 
preterm infants[70] and its impact upon lactation,[26] and supplementation where 
necessary.[7] Beyond infancy, the optimal pattern of growth for respiratory health is unclear. 
Whilst there is evidence that asthma risk is increased in teenagers who were born small for 
gestational age but later become obese,[71] no studies have specifically considered the 
impact of nutrition and growth upon respiratory outcomes in late preterm infants who, as a 
group, appear to be at increased risk of both early growth restriction[4, 7] and later 
obesity.[2]  
 
5.2.2 RSV prophylaxis 
Late preterm infants do not generally receive RSV prophylaxis, despite findings from the 
IMpact clinical trial demonstrating benefit to infants born up to and including 35 weeks 
gestation[72]. It has been suggested that vaccination programmes could be extended to less 
premature infants, particularly if those most at risk could be identified. The Italian FLIP study 
(Factors Leading to RSV-related Infection and hospitalisation among Premature infants) 
produced a model of seven variables predicting RSV-related hospitalisation in infants born at 
33–35 weeks’ gestation: predictors were gender, birth weight, birth within 10 weeks of start 
of season, breastfeeding for less than 2 months, siblings older than 2 years, and family 
history of atopy or wheeze.[73] Interestingly, given that considerable data exist supporting 
an association between parental smoking and lower respiratory tract infection, smoking was 
not included amongst these risk factors. Children from smoking households without RSV 
prophylaxis have, however, been found in a meta-analysis of FLIP-study and other data to be 
at 2.53 (95% CI 1.27-4.94) times greater risk of RSV hospitalisation compared to children 
living in non-smoking households.[74] Smoking was found to be correlated with a number of 
other risk factors for RSV hospitalisation, potentially explaining why it was not included in the 
FLIP model. In infants receiving RSV prophylaxis the risk of RSV hospitalisation did not differ 
significantly in smoking and non-smoking households. Taken together these findings suggest 
parents of late term infants should be supported in smoking cessation and that a risk factor-
based approach might identify infants likely to benefit most from vaccination. 
 
Integrated healthcare data from 71,102 children born in Northern California at 32 weeks of 
gestation or later found the risk of recurrent wheeze to be elevated in those with a previous 
RSV infection compared with those without.[43] Evidence is emerging that this association 
might reflect a causal relationship. If susceptibility to RSV places preterm infants at greater 
risk of altered immune or lung development, RSV infection should be regarded as an 
important cause of subsequent wheezing in this population. Indeed, non-randomised trials of 
measures to reduce RSV infection in preterm infants have demonstrated that prevention of 
infection might reduce the number of days of symptomatic wheeze in the first year of life, 
although this protection appears possibly limited to non-atopic infants.[76] 
 
6 Conclusion 
Babies born late preterm are at increased risk of respiratory morbidity. Late preterm delivery 
interrupts normal lung development and is associated with obstetric complications and 
neonatal morbidities which compound the adverse developmental consequences of preterm 
birth. Infants born late preterm have poorer lung function from birth than infants born at 
term. Relative lung function deficits persist through infancy and late preterm birth appears to 
be associated with an increased risk of wheeze in childhood. The challenge now is to identify 
those individuals most at risk and to develop interventions which minimise the consequences 
of impaired lung development and where possible promote normal development of the 
respiratory system.
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